Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evommune (EVMN) Treasury Shares (2024 - 2025)

Evommune (EVMN) has disclosed Treasury Shares for 2 consecutive years, with $328318.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 25.0% to $328318.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $328318.0 through Dec 2025, down 25.0% year-over-year, with the annual reading at $328318.0 for FY2025, 25.0% down from the prior year.
  • Treasury Shares for Q4 2025 was $328318.0 at Evommune, down from $444992.0 in the prior quarter.
  • The five-year high for Treasury Shares was $444992.0 in Q3 2025, with the low at $328318.0 in Q4 2025.